Beryl Drugs Ltd share price logo

Beryl Drugs Ltd

BSE: 524606

Small Cap

Pharma Sector

₹23.52

+0.02

(+0.09%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Beryl Drugs Stock Performance

as on June 29, 2026 at 5:35 pm IST

  • Day's Low

    Day's High

    ₹22.01
    ₹24.39
    downward going graph

    6.42%

    Downside

    3.70%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹15.92
    ₹30.00
    downward going graph

    32.31%

    Downside

    27.55%

    Upside

    downward going graph

Beryl Drugs share price movements today

Previous Close
₹23.50
Open
₹24.39
Volume
92.00
Upper Circuit
₹25.85
Lower Circuit
₹21.15
Day's Low - High
₹22.01 - ₹24.39
52 Week Low - High
₹15.92 - ₹30.00

Beryl Drugs Historical Returns

1 Month Return
+ 12.76 %
3 Month Return
+ 21.89 %
1 Year Return
+ 10.38 %
3 Year Return
+ 43.29 %
5 Year Return
+ 193.38 %

Beryl Drugs Fundamentals

as on June 29, 2026 at 12:05 pm IST

Market Cap

₹11.92 Cr

Return on Equity (ROE)

6.3

PE Ratio (TTM)

0

Return on capital employed (ROCE)

9.93

Beta (LTM)

0.83

P/B Ratio

1.13

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

273.33

EPS (TTM)

0

Book Value

0

Beryl Drugs Technical Analysis

Track how Beryl Drugs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish2
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-0.28
Bearish
CCI (20)
-277.73
Bullish
RSI (14)
0
Bullish
Momentum (10)
-1.51
Neutral
ADI (14)
66.49
Bearish
Ultimate Oscillator (7,14,28)
0
Bearish

Moving Averages

Name

Value

Action

SMA (20)
23.29
Bearish
EMA (20)
23.13
Bearish
VWMA (20)
23.11
Bearish
SMA (50)
23.43
Bearish
EMA (50)
23.35
Bearish
SMA (200)
23.57
Bearish
EMA (200)
23.51
Bearish
KAMA (200)
22.27
Bearish
DEMA (200)
23.45
Bearish

Beryl Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beryl Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.9238.68%0.00-121
Solara Active Pharma Sciences Ltd image
Solara Active Pharma Sciences Ltd
NA2,714.37-13.29%0.72-5671,283
Panjon Ltd image
Panjon Ltd
NA30.439.77%0.00-530
Brawn Biotech Ltd image
Brawn Biotech Ltd
NA6.813.51%0.00-213
Samrat Pharmachem Ltd image
Samrat Pharmachem Ltd
NA66.98-1.55%0.007285
See all

Beryl Drugs Stock’s Investor Sentiment and Interest

Search interest for Beryl Drugs Ltd Stock has increased by 158% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:158% versus previous 30 day period

Beryl Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
8.11
8.03
7.62
2.98
6.25
5.61
5.31
3.97
4.79
5.12
3.78
5.13
Total Income
8.17
8.09
7.66
3.21
6.29
5.65
5.4
5.22
4.84
5.16
3.85
5.47
Expenses
7.04
7.37
6.86
3.18
5.3
5.08
4.81
4.72
4.28
4.42
4.05
4.13
Operating Profit
1.07
0.66
0.76
-0.2
0.95
0.53
0.5
-0.75
0.51
0.7
-0.27
1
Operating Profit Margin %
13.19%
8.22%
9.97%
-6.71%
15.2%
9.45%
9.42%
-18.89%
10.65%
13.67%
-7.14%
19.49%
Profit Before Interest, Tax and Depreciation
1.13
0.72
0.8
0.03
0.99
0.57
0.59
0.5
0.55
0.73
-0.2
1.34
Interest
0.12
0.1
0.11
0.13
0.21
0.12
0.12
0.08
0.1
0.08
0.09
0.07
Depreciation
0.28
0.29
0.31
0.32
0.28
0.33
0.31
0.32
0.38
0.39
0.32
0.4
Profit Before Tax
0.73
0.33
0.38
-0.42
0.5
0.12
0.16
0.1
0.07
0.26
-0.61
0.87
Tax Paid
0.2
0.06
0.06
-0.07
0.13
0.1
0.1
-0.05
0.05
0.25
-0.44
0.3
Profit After Tax
0.53
0.27
0.31
-0.35
0.37
0.01
0.05
0.15
0.02
0.01
-0.17
0.56
Total Net profit including share of profit / Loss from associate company
0.53
0.27
0.31
-0.35
0.37
0.01
0.05
0.15
0.02
0.01
-0.17
0.56
EPS
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
0.02
-0.33
1.11
Actual EPS
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
0.02
-0.33
1.11
Adjusted EPS
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
0.02
-0.33
1.11
Diluted EPS
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
0.02
-0.33
1.11

Beryl Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
15.25
12.96
12.82
14.09
14.6
26.89
26.73
21.15
18.82
Other Income
0.69
-
-
0.45
-
-
-
-
-
Total Income
15.94
13.2
13.05
14.73
14.77
27.16
27.12
22.55
19.31
Expenses
14.21
11.94
11.91
12.64
14.2
24.94
24.45
19.91
16.88
Operating Profit
1.04
1.02
0.91
1.45
0.4
1.95
2.28
1.24
1.94
Operating Profit Margin %
6.82%
7.87%
7.1%
10.29%
2.74%
7.25%
8.53%
5.86%
10.31%
Profit Before Interest, Tax and Depreciation
1.74
1.27
1.14
2.09
0.57
2.21
2.67
2.64
2.43
Interest
0.13
0.15
0.32
0.47
0.44
0.42
0.46
0.53
0.34
Depreciation
0.33
0.32
0.66
1.27
1.09
0.81
1.2
1.25
1.49
Profit Before Tax
1.28
0.8
0.16
0.35
-0.96
0.98
1.01
0.86
0.6
Tax Paid
0.28
0.21
0.11
0.11
-0.29
0.22
0.24
0.29
0.16
Profit After Tax
0.99
0.59
0.05
0.24
-0.66
0.77
0.77
0.58
0.42
Total Net profit including share of profit / Loss from associate company
0.99
0.59
0.05
0.24
-0.66
0.77
0.77
0.58
0.42
EPS
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
0.84
Actual EPS
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
0.84
Adjusted EPS
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
0.84
Diluted EPS
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
0.84

Beryl Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.13
0.37
-0.1
3.35
0.18
0.34
-0.29
2.48
0.82
2.64
Cash Flow from Investing Activities
0.17
0.32
0.05
1.15
-1.56
0.26
0.53
-1.3
-1.08
-0.41
Cash Flow from Financing Activities
-0.23
-0.19
-0.36
1.61
1.67
-0.54
-0.43
-1.17
0.11
-1.55
Net Cash Flow
-0.19
0.5
-0.49
-0.04
0.3
0.06
-0.18
0.01
-0.16
0.69

Beryl Drugs Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
27.48%
Public
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
72.52%
Total Outstanding Shares
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
Total Shareholders
6,805
6,852
7,257
7,325
7,364
7,429
7,431
7,415
7,446
7,409
7,349

Beryl Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Beryl Drugs.

  • Beryl Drugs Ltd Earnings Results

    Beryl Drugs Ltd’s net profit jumped 273.33% since last year same period to ₹0.56Cr in the Q4 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated 429.41% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Beryl Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 26.38% to 27.48% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Beryl Drugs stock has moved up by 7.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.5% return, outperforming this stock by 22.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.1% return, outperforming this stock by 93.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 73.62% to 72.52% in Mar 2026 quarter

About Beryl Drugs Ltd

Beryl Drugs Ltd is a leading generic pharmaceutical manufacturing company based in Indore, India, providing a range of branded and generic formulations, I.V.fluids, a range of small and large volume injectables, eye/ear drops, veterinary products and injections. Established in 1993, with operations taken over from M/s Flora and Fauna Remedies, Beryl Drugs have successfully set up a global network of pharmaceutical manufacturing research and development, contract manufacturing services, and veterinary products. The company is in compliance with WHO GMP specifications, and has also achieved ISO 9001:2000 certification for their quality management. Beryl Drugs are popular for many of their branded products like BERICEF injection, FNeuron Amplicillin INJ, PMol Biprox, BFlox and many more.

Revenue: ₹5.13Cr as on March 2026 (Q4 FY26)
Net Profit: ₹0.56Cr as on March 2026 (Q4 FY26)
Chairperson Name: Sudhir Sethi
OrganisationBeryl Drugs Ltd
IndustryPharmaceuticals
CEOSudhir Sethi
E-voting on sharesClick here to vote

FAQs

What is Beryl Drugs share price today?

Beryl Drugs share price today stands at ₹23.52 as on . Beryl Drugs share today touched a day high of ₹24.39 and a low of ₹22.01.

What is the 52 week high and 52 week low range for Beryl Drugs share?

Beryl Drugs touched a 52 week high of ₹30 and a 52 week low of ₹15.92. Beryl Drugs share price today i.e. is trending at ₹23.52, which is -21.60% down from its 52 week high and 47.74% up from its 52 week low.

What is Beryl Drugs's market capitalisation today?

Beryl Drugs market capitalisation is ₹11.92 Cr as on .

How to buy Beryl Drugs shares?

To buy Beryl Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524606 or Beryl Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Beryl Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Beryl Drugs trading volume today?

Beryl Drugs trading volume is 92.00 as on . This means that 92.00 shares of Beryl Drugs were bought and sold on the stock market during today's trading session.